197 related articles for article (PubMed ID: 31468270)
1. Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience.
Tsang DS; Sarhan N; Ramaswamy V; Nobre L; Yee R; Taylor MD; Hawkins C; Bartels U; Huang A; Tabori U; Hodgson DC; Bouffet E; Laperriere N
J Neurooncol; 2019 Oct; 145(1):107-114. PubMed ID: 31468270
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
3. Repeat irradiation for children with supratentorial high-grade glioma.
Tsang DS; Oliveira C; Bouffet E; Hawkins C; Ramaswamy V; Yee R; Tabori U; Bartels U; Huang A; Millar BA; Crooks B; Bowes L; Zelcer S; Laperriere N
Pediatr Blood Cancer; 2019 Sep; 66(9):e27881. PubMed ID: 31207154
[TBL] [Abstract][Full Text] [Related]
4. Outcomes After Reirradiation for Recurrent Pediatric Intracranial Ependymoma.
Tsang DS; Burghen E; Klimo P; Boop FA; Ellison DW; Merchant TE
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):507-515. PubMed ID: 29229328
[TBL] [Abstract][Full Text] [Related]
5. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
6. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
Baroni LV; Freytes C; Fernández Ponce N; Oller A; Pinto N; Gonzalez A; Maldonado FR; Sampor C; Rugilo C; Lubieniecki F; Alderete D
J Neurooncol; 2021 Oct; 155(1):53-61. PubMed ID: 34505229
[TBL] [Abstract][Full Text] [Related]
7. Interstitial brachytherapy using stereotactic implanted (125)iodine seeds for recurrent medulloblastoma.
El Majdoub F; Simon T; Hoevels M; Berthold F; Sturm V; Maarouf M
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):532-7. PubMed ID: 21440428
[TBL] [Abstract][Full Text] [Related]
8. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Ramaswamy V; Remke M; Bouffet E; Faria CC; Perreault S; Cho YJ; Shih DJ; Luu B; Dubuc AM; Northcott PA; Schüller U; Gururangan S; McLendon R; Bigner D; Fouladi M; Ligon KL; Pomeroy SL; Dunn S; Triscott J; Jabado N; Fontebasso A; Jones DT; Kool M; Karajannis MA; Gardner SL; Zagzag D; Nunes S; Pimentel J; Mora J; Lipp E; Walter AW; Ryzhova M; Zheludkova O; Kumirova E; Alshami J; Croul SE; Rutka JT; Hawkins C; Tabori U; Codispoti KE; Packer RJ; Pfister SM; Korshunov A; Taylor MD
Lancet Oncol; 2013 Nov; 14(12):1200-7. PubMed ID: 24140199
[TBL] [Abstract][Full Text] [Related]
9. Tumor bed proton irradiation in young children with localized medulloblastoma.
Grewal AS; Li Y; Fisher MJ; Minturn J; Paltin I; Belasco J; Phillips P; Kang T; Lustig RA; Hill-Kayser C
Pediatr Blood Cancer; 2019 Dec; 66(12):e27972. PubMed ID: 31512390
[TBL] [Abstract][Full Text] [Related]
10. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
11. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M; Vennarini S; Buttarelli FR; Antonelli M; Colombo F; Minasi S; Pecori E; Ferroli P; Giussani C; Schiariti M; Schiavello E; Biassoni V; Erbetta A; Chiapparini L; Nigro O; Boschetti L; Gianno F; Miele E; Modena P; De Cecco L; Pollo B; Barretta F
J Neurooncol; 2023 Jul; 163(3):577-586. PubMed ID: 37326761
[TBL] [Abstract][Full Text] [Related]
12. Salvage Re-irradiation Options in Adult Medulloblastoma: A Case Report and Review of the Literature.
Cuccia F; Mortellaro G; Ognibene L; Craparo G; Lo Casto A; Ferrera G
In Vivo; 2020; 34(3):1283-1288. PubMed ID: 32354920
[TBL] [Abstract][Full Text] [Related]
13. Intellectual Outcome in Molecular Subgroups of Medulloblastoma.
Moxon-Emre I; Taylor MD; Bouffet E; Hardy K; Campen CJ; Malkin D; Hawkins C; Laperriere N; Ramaswamy V; Bartels U; Scantlebury N; Janzen L; Law N; Walsh KS; Mabbott DJ
J Clin Oncol; 2016 Dec; 34(34):4161-4170. PubMed ID: 27507873
[TBL] [Abstract][Full Text] [Related]
14. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
Gururangan S; Krauser J; Watral MA; Driscoll T; Larrier N; Reardon DA; Rich JN; Quinn JA; Vredenburgh JJ; Desjardins A; McLendon RE; Fuchs H; Kurtzberg J; Friedman HS
Neuro Oncol; 2008 Oct; 10(5):745-51. PubMed ID: 18755919
[TBL] [Abstract][Full Text] [Related]
16. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors of radiation therapy for medulloblastoma.
Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
Ramaswamy V; Remke M; Adamski J; Bartels U; Tabori U; Wang X; Huang A; Hawkins C; Mabbott D; Laperriere N; Taylor MD; Bouffet E
Neuro Oncol; 2016 Feb; 18(2):291-7. PubMed ID: 25605817
[TBL] [Abstract][Full Text] [Related]
20. [Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].
Golubicić I; Bokun J; Nikitović M; Mladenović J; Sarić M; Bekić Z
Srp Arh Celok Lek; 2003; 131(5-6):226-31. PubMed ID: 14692129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
